Requirement for the SnoN oncoprotein in transforming growth factor beta-induced oncogenic transformation of

Qingwei Zhu1, Sonia Pearson-White, Kunxin Luo

  • 1Department of Molecular and Cell Biology, University of California, Berkeley, 94720-3204, USA.

Insights

Transforming growth factor beta (TGF-beta) uses SnoN to promote fibroblast proliferation and transformation. This involves prolonged SnoN induction via Smad2, contrasting with Smad3

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Oncology

Background:

  • Transforming growth factor beta (TGF-beta) exhibits dual roles: inhibiting epithelial cell growth but inducing fibroblast transformation.
  • The Smad-dependent growth-inhibitory pathway of TGF-beta is understood, yet the mechanism driving fibroblast transformation remains unclear.
  • SnoN, a Ski family oncoprotein, is implicated in cellular processes but its role in TGF-beta-induced fibroblast transformation requires elucidation.

Purpose of the Study:

  • To investigate the role of SnoN in TGF-beta-induced proliferation and transformation of AKR-2B and NRK fibroblasts.
  • To elucidate the signaling pathways, particularly Smad protein involvement, regulating snoN expression and TGF-beta's transforming activity.
  • To explore the differential roles of Smad2 and Smad3 in controlling snoN transcription and its implications in cancer.

Main Methods:

  • Utilized small interfering RNA (siRNA) to reduce snoN expression and pharmacological inhibitors to modulate snoN induction duration.
  • Analyzed snoN gene and protein expression levels in response to TGF-beta stimulation in fibroblasts and epithelial cells.
  • Investigated Smad protein complex interactions with the snoN promoter using reporter assays and analysis of Smad4 mutations.

Main Results:

  • SnoN is essential for TGF-beta-induced proliferation and transformation of AKR-2B and NRK fibroblasts.
  • TGF-beta upregulates snoN expression via a common Smad-dependent pathway, with prolonged induction observed specifically in fibroblasts.
  • Smad2/Smad4 activates snoN transcription, while Smad3/Smad4 inhibits it; Smad4 mutations in cancer alter this balance, increasing snoN expression.

Conclusions:

  • SnoN plays a critical role in mediating the transforming activity of TGF-beta in fibroblasts.
  • Prolonged Smad2-mediated snoN induction is a key mechanism underlying TGF-beta-induced fibroblast transformation.
  • Dysregulation of Smad2/Smad3 interactions with Smad4 contributes to elevated snoN expression in certain human cancers.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...